ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
軒竹生物-B
29.000
+2.700
10.27%
手動刷新
成交量:
239.37萬
成交額:
6,160.11萬
市值:
150.20億
市盈率:
- -
高:
29.000
開:
26.100
低:
23.820
收:
26.300
52周最高:
31.000
52周最低:
23.820
股本:
5.18億
香港流通股本:
1.61億
量比:
0.16
換手率:
1.49%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
16.28
市盈率(LYR):
- -
市銷率:
430.94
資料載入中...
總覽
公司
新聞
公告
多隻醫藥新股上市頭日收漲超100%!包括曾申報科創板IPO未果的新股
制药网
·
昨天
異動解讀 | 軒竹生物-B盤中大漲5.17%,新藥研發及商業化進展獲市場認可
异动解读
·
昨天
異動解讀 | 軒竹生物-B上市次日大跌6.54%,或因獲利回吐及估值調整
异动解读
·
昨天
異動解讀 | 軒竹生物-B上市次日盤中大跌6.54%,高開低走或因獲利回吐
异动解读
·
昨天
港股綜述 | 科指漲2.57%,阿里漲近4%;三花智控漲近13%,軒竹生物首日飆升126%
老虎资讯综合
·
10/15
大漲167%!A股、港股,盤中異動!
券商中国
·
10/15
市值超130億,山東富豪收穫一個IPO
猎云网
·
10/15
四環醫藥(00460.HK):軒竹生物10月15日在聯交所主板上市
中金财经
·
10/15
H拆H:開盤漲超153%,軒竹生物今日港股上市
药时空
·
10/15
開盤漲超153%!軒竹生物登陸港交所 依舊難掩「造血」焦慮
21世纪经济报道
·
10/15
「雙輪驅動+商業化三駕馬車」,軒竹生物-B(02575)劍指港市Biopharma新標杆
智通财经
·
10/15
軒竹生物登陸港交所開盤平開,總市值156億港元
瑞财经
·
10/15
異動解讀 | 軒竹生物-B上市首日大漲163.79%,創新藥管線引發投資熱潮
异动解读
·
10/15
新股首日|軒竹生物-B首掛高開近154%,中籤一手賺8930港元
老虎资讯综合
·
10/15
軒竹生物-B股票香港上市首日預計以每股29.46港元開盤 發行價為每股11.60港元
美股速递
·
10/15
從Biotech到Biopharma的跨越:軒竹生物-B(2575.HK)以「三輪驅動」構建國產創新藥核心競爭力
格隆汇
·
10/15
軒竹生物-B港股暗盤現漲超158%,報30.00港元
每日经济新闻
·
10/14
港股四環醫藥旗下軒竹生物-B暗盤漲超140%,成交量超250萬手,振幅達100.86%
新浪财经
·
10/14
老虎暗盤 | 軒竹生物-B漲超200%,中籤一手賺約11700港元
老虎资讯综合
·
10/14
軒竹生物XZP - 7797 - H1片啓動Ⅰ期臨牀 適應症為晚期實體瘤
新浪财经
·
10/11
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02575/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"軒竹生物-B","latestPrice":29,"timestamp":1760602151605,"preClose":26.3,"halted":0,"volume":2393651,"delay":0,"floatShares":160701996,"shares":517947790,"eps":0,"marketStatus":"未開盤","change":2.7,"latestTime":"10-16 16:09:11","open":26.1,"high":29,"low":23.82,"amount":61601096,"amplitude":0.196958,"askPrice":29,"askSize":11000,"bidPrice":28.42,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1760664600000},"marketStatusCode":0,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":26.3,"openAndCloseTimeList":[[1760578200000,1760587200000],[1760590800000,1760601600000]],"volumeRatio":0.162345,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":160701996,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.16234452346690179,"shares":517947790,"dividePrice":0,"high":29,"amplitude":0.196958,"preClose":26.3,"low":23.82,"week52Low":23.82,"pbRate":"16.28","psRate":"430.94","week52High":31,"institutionHeld":0,"latestPrice":29,"committee":-0.913043,"eps":0,"divideRate":0,"volume":2393651,"delay":0,"ttmEps":0,"open":26.1,"prevYearClose":11.6,"prevWeekClose":11.6,"prevMonthClose":11.6,"prevQuarterClose":11.6,"fiveDayClose":11.6,"twentyDayClose":11.6,"sixtyDayClose":11.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2025-10-15","current":-22.444691,"percent":1,"low":-22.444691,"twenty":-22.444691,"median":-22.444691,"eighty":-22.444691,"high":-22.444691,"avg":-22.444691,"sd":0,"marketCap":13622026877},"quantilePoints":[{"date":"2025-10-15","current":-22.444691,"twenty":-22.444691,"median":-22.444691,"eighty":-22.444691,"marketCap":13622026877}],"updateTime":1760642413208},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575530714","title":"多隻醫藥新股上市頭日收漲超100%!包括曾申報科創板IPO未果的新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575530714","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575530714?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 16:58","pubTimestamp":1760605089,"startTime":"0","endTime":"0","summary":"银诺医药的暴涨更凸显了市场对核心创新资产的追捧。中国已成为全球第二大医药市场,其中创新药领域增长尤为迅猛。医药研发具有周期长、投入大、风险高的特点,一款新药从临床前研究到上市平均需投入 10 亿美元以上,成功率不足 10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575","09939","BK1574","00460","BK1161","BK1515"],"gpt_icon":1},{"id":"1109943861","title":"異動解讀 | 軒竹生物-B盤中大漲5.17%,新藥研發及商業化進展獲市場認可","url":"https://stock-news.laohu8.com/highlight/detail?id=1109943861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109943861?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 15:00","pubTimestamp":1760598034,"startTime":"0","endTime":"0","summary":"10月16日,轩竹生物-B股价盘中大涨5.17%,延续了其上市以来的强劲表现。该公司于10月15日在港交所挂牌上市,上市首日即大涨126.72%,显示出投资者对这家创新生物制药公司的高度认可。尽管轩竹生物目前仍处于亏损阶段,但其商业化进程正在加速。市场普遍认为,随着公司产品线的不断丰富和商业化能力的提升,轩竹生物有望在未来实现快速增长。此次上市融资约7.01亿港元,将进一步支持公司的研发和商业化战略,为其长远发展奠定基础。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":1},{"id":"1153186772","title":"異動解讀 | 軒竹生物-B上市次日大跌6.54%,或因獲利回吐及估值調整","url":"https://stock-news.laohu8.com/highlight/detail?id=1153186772","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153186772?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 09:34","pubTimestamp":1760578467,"startTime":"0","endTime":"0","summary":"港股新上市公司轩竹生物-B今日盘中大跌6.54%,引发市场关注。该公司昨日刚在港交所挂牌上市,首日表现强劲,收盘大涨126.72%。轩竹生物是一家创新驱动的生物制药公司,专注于消化系统疾病、肿瘤和非酒精性脂肪性肝炎等领域的药物研发。公司目前已有三款商业化产品,并拥有超过十种在研药物资产。尽管短期内股价出现波动,但投资者在关注该股时,需要同时考虑其创新能力、商业化进展以及整体行业环境等多重因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":0},{"id":"1100747627","title":"異動解讀 | 軒竹生物-B上市次日盤中大跌6.54%,高開低走或因獲利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1100747627","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100747627?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 09:32","pubTimestamp":1760578351,"startTime":"0","endTime":"0","summary":"港股新上市公司轩竹生物-B今日盘中大跌6.54%,引发市场关注。该公司昨日刚在港交所挂牌上市,首日表现强劲,收盘大涨126.72%。轩竹生物是一家创新驱动的生物制药公司,专注于消化系统疾病、肿瘤和非酒精性脂肪性肝炎等领域的药物研发。公司目前已有三款商业化产品,并拥有超过十种在研药物资产。尽管收入呈增长趋势,但公司仍处于亏损状态。虽然短期内股价出现波动,但轩竹生物的长期发展前景仍值得关注。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":0},{"id":"1176591756","title":"港股綜述 | 科指漲2.57%,阿里漲近4%;三花智控漲近13%,軒竹生物首日飆升126%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176591756","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176591756?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 16:43","pubTimestamp":1760517801,"startTime":"0","endTime":"0","summary":"港股行情港股三大指数集体上涨,恒生科技指数涨2.57%重回6000点大关,恒生指数、国企指数分别上涨1.84%及1.89%。另一方面,影视股、海运股、稀土概念股少部分板块低迷,此外,$轩竹生物-B$首日上市大幅收涨126.72%。个股方面:由四环医药分拆的$轩竹生物-B$今日首日上市,大涨126.72%,报26.3港元。A股行情A股三大指数齐升,上证指数涨1.22%重回3900点,深证成指涨1.73%,创业板指大涨2.36%。","market":"sh","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","01211","00981","02050","HSI","02575"],"gpt_icon":1},{"id":"2575208788","title":"大漲167%!A股、港股,盤中異動!","url":"https://stock-news.laohu8.com/highlight/detail?id=2575208788","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575208788?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 14:46","pubTimestamp":1760510775,"startTime":"0","endTime":"0","summary":"创新药,集体异动!今日(10月15日),在港股市场上,创新药概念股大幅异动,新股轩竹生物一度暴涨167%,若不计手续费,每手(500股)最高可赚约9700港元。在A股市场上,创新药概念股也集体拉升,亚太药业、昂利康、济民健康等多股涨停。港股新股大涨10月15日,创新药概念股轩竹生物在港交所挂牌上市,该股开盘报29.46港元/股,较发行价(11.60港元/股)上涨153.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510153534810925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","06978","BK4500","BK4570","BK1161","ALK","02575","PPI","BK4585","BK4008","BK1574"],"gpt_icon":1},{"id":"2575058271","title":"市值超130億,山東富豪收穫一個IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2575058271","media":"猎云网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575058271?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 12:55","pubTimestamp":1760504132,"startTime":"0","endTime":"0","summary":"每股发售价11.6港元,开盘涨153.97%至29.46港元;截至午间休盘,每股涨128.45%至26.5港元,总市值137.26亿。截至目前,四环医药总市值已超130亿港元,截至最后实际可行日期,轩竹生物有超过十种药物资产在积极开发中,涵盖消化系统疾病、肿瘤和非酒精性脂肪性肝炎。截至最后实际可行日期,轩竹生物有三项NDA批准资产,一个药物项目处于NDA注册阶段,一个药物项目处于III期临床试验阶段,四个药物项目处于I期临床试验阶段,五个已获IND批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015125550972ee2a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015125550972ee2a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","02575"],"gpt_icon":1},{"id":"2575271662","title":"四環醫藥(00460.HK):軒竹生物10月15日在聯交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2575271662","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575271662?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 12:37","pubTimestamp":1760503021,"startTime":"0","endTime":"0","summary":"格隆汇10月15日丨四环医药(00460.HK)宣布,关建议分拆及公司附属公司轩竹生物于联交所主板独立上市。于全球发售完成后,分拆公司于2025年10月15日在联交所主板上市,而分拆公司H股于2025年10月15日上午九时正开始于联交所主板买卖。\r\n\r\n \r\n\r\n 【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251015/31707892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","00460","02575","BK1593","BK1191","BK1600"],"gpt_icon":0},{"id":"2575276096","title":"H拆H:開盤漲超153%,軒竹生物今日港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2575276096","media":"药时空","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575276096?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 11:51","pubTimestamp":1760500287,"startTime":"0","endTime":"0","summary":"今日,轩竹生物正式港股上市,开盘涨超153%。轩竹生物作为背靠四环医药的“创二代”,其港股IPO无疑成为市场焦点。财务数据显示,轩竹生物目前仍未扭亏。2023年、2024年及2025年6月30日止六个月,轩竹生物分别实现收入2.9万元、3009.4万元及1789.3万元,同期亏损总额分别为3.01亿元、5.56亿元及1.11亿元,累计亏损超9亿元。2022年,轩竹生物首次申报科创板IPO,并于2024年5月撤回申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015115659972ecd17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015115659972ecd17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","00460","02575","BK1593","BK1191","BK1600"],"gpt_icon":1},{"id":"2575278297","title":"開盤漲超153%!軒竹生物登陸港交所 依舊難掩「造血」焦慮","url":"https://stock-news.laohu8.com/highlight/detail?id=2575278297","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575278297?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 10:25","pubTimestamp":1760495129,"startTime":"0","endTime":"0","summary":"【开盘涨超153%!轩竹生物登陆港交所 依旧难掩“造血”焦虑】对于当前生物医药企业赴港上市热潮,香港生产力促进局首席数码总监及内地业务首席执行官黎少斌在接受记者采访时表示,“内地药企进入香港市场的过程中,两地有望在产品研发、市场战略、资金运作等领域深化合作。除融资优势外,香港在生命健康领域拥有世界领先的科研基础设施与成熟监管环境,将为内地企业布局国际市场提供重要支撑。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202510153534636140.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202510153534636140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["02575"],"gpt_icon":1},{"id":"2575220514","title":"「雙輪驅動+商業化三駕馬車」,軒竹生物-B(02575)劍指港市Biopharma新標杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2575220514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575220514?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:42","pubTimestamp":1760492543,"startTime":"0","endTime":"0","summary":"上市当日,轩竹生物股价早盘冲高至最高31港元,涨幅高达167%。凭借自身消化+肿瘤双轮驱动下形成的产品端“三驾马车”,轩竹生物在国内填补临床空白的优势的同时,也在依托自身强劲的商业化推进能力,持续开辟更广阔的适应症市场,彰显公司Biopharma的底色。目前公司正加速差异化创新,Biopharma价值获进一步验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02575"],"gpt_icon":1},{"id":"2575227735","title":"軒竹生物登陸港交所開盤平開,總市值156億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575227735","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575227735?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:36","pubTimestamp":1760492192,"startTime":"0","endTime":"0","summary":"10月15日,轩竹生物-B(02575)在港交所挂牌上市,独家保荐人为中金公司,开盘平开,总市值156.01亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101509364194c9c16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101509364194c9c16c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"1131136011","title":"異動解讀 | 軒竹生物-B上市首日大漲163.79%,創新藥管線引發投資熱潮","url":"https://stock-news.laohu8.com/highlight/detail?id=1131136011","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131136011?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:32","pubTimestamp":1760491949,"startTime":"0","endTime":"0","summary":"轩竹生物-B今日在港交所主板正式挂牌上市,盘中股价大涨163.79%,引发市场广泛关注。该股上市首日表现亮眼,充分反映了投资者对创新生物制药企业的热情。轩竹生物-B此次IPO定价为每股11.60港元,共发行6733.35万股H股。上市首日开盘价为29.46港元,较发行价上涨153.97%,随后继续攀升。分析人士指出,轩竹生物-B的强劲表现不仅反映了公司自身的研发实力和商业化潜力,也体现了投资者对中国生物医药行业整体前景的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02575"],"gpt_icon":1},{"id":"2575165792","title":"新股首日|軒竹生物-B首掛高開近154%,中籤一手賺8930港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575165792","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575165792?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:25","pubTimestamp":1760491500,"startTime":"0","endTime":"0","summary":"智通财经APP讯,轩竹生物-B(02575)公布配发结果,公司全球发售6733.35万股H股,香港公开发售占10%,国际发售占90%。每股发售价11.6港元,全球发售净筹约7.01亿港元。每手500股,预期H股将于2025年10月15日(星期三)上午九时正(香港时间)开始在联交所买卖。其中,香港公开发售获4,908.33倍认购,国际发售获10.15倍认购。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355027.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"轩竹生物-B每股发售价11.6港元,香港公开发售获4908.33倍认购","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"1105061473","title":"軒竹生物-B股票香港上市首日預計以每股29.46港元開盤 發行價為每股11.60港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105061473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105061473?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:23","pubTimestamp":1760491407,"startTime":"0","endTime":"0","summary":"轩竹生物-B股票香港上市首日预计以每股29.46港元开盘 发行价为每股11.60港元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2575227584","title":"從Biotech到Biopharma的跨越:軒竹生物-B(2575.HK)以「三輪驅動」構建國產創新藥核心競爭力","url":"https://stock-news.laohu8.com/highlight/detail?id=2575227584","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575227584?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 09:21","pubTimestamp":1760491317,"startTime":"0","endTime":"0","summary":"轩竹生物此次港股上市,不仅是公司发展的里程碑,更是其从Biotech向Biopharma转型的“价值重估起点”。","market":"hk","thumbnail":"https://img2.gelonghui.com/b17e2-d966b981-20ff-4967-8590-d40f85d09213.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-d966b981-20ff-4967-8590-d40f85d09213.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2994657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","BK1161","06978","02575"],"gpt_icon":1},{"id":"2575744262","title":"軒竹生物-B港股暗盤現漲超158%,報30.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575744262","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575744262?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 16:38","pubTimestamp":1760431088,"startTime":"0","endTime":"0","summary":"轩竹生物-B港股暗盘现涨超158%,报30.00港元","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510143533650323.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510143533650323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02575"],"gpt_icon":0},{"id":"2575267142","title":"港股四環醫藥旗下軒竹生物-B暗盤漲超140%,成交量超250萬手,振幅達100.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575267142","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575267142?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 16:27","pubTimestamp":1760430477,"startTime":"0","endTime":"0","summary":"港股 四环医药 旗下轩竹生物-B暗盘涨超140%,成交量超250万手,振幅达100.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014164037a6b8a7b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014164037a6b8a7b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1515","BK1600","02575","BK1593","BK1191"],"gpt_icon":0},{"id":"1185100446","title":"老虎暗盤 | 軒竹生物-B漲超200%,中籤一手賺約11700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185100446","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185100446?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 16:16","pubTimestamp":1760429760,"startTime":"0","endTime":"0","summary":"轩竹生物-B涨超200%,总市值突破180亿港元!截至最后实际可行日期,公司有超过十种药物资产在积极开发中,涵盖消化系统疾病、肿瘤和NASH。公司推动药物开发的速度及执行力卓越,借此脱颖而出,截至最后实际可行日期已获得共20项IND批准。轩竹生物已经建立一个全面的内部研发平台,作为公司业务的基石和长期增长的动力。通过自主研发和资产对外授权双轨制,公司已迅速将这些候选药物推向市场,并已获得或提交七项NDA。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":1},{"id":"2574339934","title":"軒竹生物XZP - 7797 - H1片啓動Ⅰ期臨牀 適應症為晚期實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2574339934","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574339934?lang=zh_tw&edition=fundamental","pubTime":"2025-10-11 12:31","pubTimestamp":1760157060,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示,轩竹生物科技股份有限公司/山东轩竹医药科技有限公司的评估XZP - 7797 - H1治疗晚期实体瘤受试者的安全性、耐受性、药代动力学特征和初步疗效的开放、多中心I期临床研究已启动。XZP - 7797 - H1片为化学药物,适应症为晚期实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101112371694c2a6be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101112371694c2a6be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}